Pharma Mar SA 2023 SR
The report details Pharma Mar's sustainability performance and strategy for the fiscal year 2023. Key highlights include joining the IBEX ESG index and achieving 90.1% of the goals in its Sustainability Action Plan 2021-2023. The company reduced its Scope 1 and 2 energy consumption per employee and square meter by 29.6% at its oncology facilities compared to the 2018-2020 average. Additionally, Pharma Mar increased its female representation on the Board of Directors to 41.7% and in management positions to 51.1%.
Company: Pharma Mar SA
Sector: Manufacturing
Country: Spain
Year: 2023
Type: SR
Pages: 119
Back to company
Pharma Mar SA
Consolidated Statement Of Non-Financial Information
The report details Pharma Mar's sustainability performance and strategy for the fiscal year 2023. Key highlights include joining the IBEX ESG index and achieving 90.1% of the goals in its Sustainability Action Plan 2021-2023. The company reduced its Scope 1 and 2 energy consumption per employee and square meter by 29.6% at its oncology facilities compared to the 2018-2020 average. Additionally, Pharma Mar increased its female representation on the Board of Directors to 41.7% and in management positions to 51.1%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees